Disease-modifying lifestyle in multiple sclerosis: evidence, challenges, and the importance of engaged, informed patients

Abstract

Evidence presents the importance of a disease-modifying lifestyle as part of a complete treatment package in multiple sclerosis, and this is now backed up with policy and guidance. However, optimised management bringing together individualised treatments, medications and lifestyle modifications requires clinical time and engaged patients. Charlie Peel explores the evidence base, presents some of the challenges, and highlights the available support for this new model of care.